Cancer - No Safe Treatments or "Cures"

Antineoplastic activity of cannabinoids
Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells
Cannabinoids and the Endocannabinoid System
Bio-Active Cannabinoids
Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation.
VIDEO - When Healing Became a Crime
Can Cannabidiol (CBD) Fight Metastatic Cancer? According to the latest research the answer is yes.
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
The endocannabinoid system in prostate cancer.
CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas
Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor.
Mechanisms of control of neuron survival by the endocannabinoid system
Cannabinoid receptors as novel targets for the treatment of melanoma.
Effects on cell viability.
JWH-133 PubMed Study Listing
the Canadian Consortium for the Investigation of Cannabinoids (CCIC) -20 Cancer Studies.
Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome.
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion
Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
1000 pages of Cannabis Research Links
Spain Study Confirms Cannabis Oil Cures Cancer Without Side Effects
422 pages of Cannabis Research
Amphiregulin is a factor for resistance of glioma cells to cannabinoid-induced apoptosis.
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism.
A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.
Budwig Diet: Dr. Johanna Budwig's Authentic Oil-Protein Healing Protocol
Aloe Vera & Tumors - Google Scholar
Cannabinoids & Tumors - Google Scholar
Curcumin & Tumors - Google Scholar